Metastatic Gallbladder Carcinoma

2 clinical trials · Condition

Record	Firm	Date
Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer (NCT04941287)	National Cancer Institute (NCI)	2021-12-15
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies (NCT04068194)	National Cancer Institute (NCI)	2020-04-07

Every clearance here is in the API, with alerts when new ones post.